Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Culine

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Drug Safety|June 1, 2000
Comparative tolerability of chemotherapy regimens for germ cell cancerS Culine, J P Droz
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Primary treatment in stage II non-seminomatous germ cell tumours of the testis: a matter of scalpel or drug infusion?S Culine, J P Droz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everythingS Culine, J P Droz
Expert Opinion on Investigational Drugs|July 5, 2005
New prospects for the treatment of germ-cell tumoursJ P Droz, S Culine
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 2, 2008
[Stage I seminoma and radiotherapy: to bury it or not?]D Pouessel, S Culine, D Azria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Oxaliplatin in non-seminomatous germ-cell tumorsK Fizazi, S Culine, I Chen
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 26, 2008
[Editorial]C Coulange, S Culine, C Hennequin
Bulletin Du Cancer|January 22, 1998
[Medical treatment of ovarian malignant germ cell tumors in the adult]S Culine, C Lhommé, J P Droz
Bulletin Du Cancer|March 1, 1993
[High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma]J Kattan, J P Droz, S Culine
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Chemotherapy of germ-cell tumors of poor prognosis and role of intensification with hematological support]J P Droz, S Culine, P Biron
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Drug Safety|June 1, 2000
Comparative tolerability of chemotherapy regimens for germ cell cancerS Culine, J P Droz
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Primary treatment in stage II non-seminomatous germ cell tumours of the testis: a matter of scalpel or drug infusion?S Culine, J P Droz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everythingS Culine, J P Droz
Expert Opinion on Investigational Drugs|July 5, 2005
New prospects for the treatment of germ-cell tumoursJ P Droz, S Culine
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 2, 2008
[Stage I seminoma and radiotherapy: to bury it or not?]D Pouessel, S Culine, D Azria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Oxaliplatin in non-seminomatous germ-cell tumorsK Fizazi, S Culine, I Chen
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 26, 2008
[Editorial]C Coulange, S Culine, C Hennequin
Bulletin Du Cancer|January 22, 1998
[Medical treatment of ovarian malignant germ cell tumors in the adult]S Culine, C Lhommé, J P Droz
Bulletin Du Cancer|March 1, 1993
[High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma]J Kattan, J P Droz, S Culine
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Chemotherapy of germ-cell tumors of poor prognosis and role of intensification with hematological support]J P Droz, S Culine, P Biron
Pageof 19